141 related articles for article (PubMed ID: 18092129)
1. Interleukin-17 gene expression in patients with rheumatoid arthritis.
Kohno M; Tsutsumi A; Matsui H; Sugihara M; Suzuki T; Mamura M; Goto D; Matsumoto I; Ito S; Suguro T; Sumida T
Mod Rheumatol; 2008; 18(1):15-22. PubMed ID: 18092129
[TBL] [Abstract][Full Text] [Related]
2. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
[TBL] [Abstract][Full Text] [Related]
3. Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis.
Kageyama Y; Ichikawa T; Nagafusa T; Torikai E; Shimazu M; Nagano A
Rheumatol Int; 2007 Dec; 28(2):137-43. PubMed ID: 17619881
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.
Tian Y; Shen H; Xia L; Lu J
J Interferon Cytokine Res; 2013 Jul; 33(7):398-401. PubMed ID: 23421370
[TBL] [Abstract][Full Text] [Related]
7. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
[TBL] [Abstract][Full Text] [Related]
8. Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.
Neregård P; Krishnamurthy A; Revu S; Engström M; af Klint E; Catrina AI
Scand J Rheumatol; 2014; 43(2):85-90. PubMed ID: 24313444
[TBL] [Abstract][Full Text] [Related]
9. Effects of TNFalpha-antagonists on nitric oxide production in human cartilage.
Vuolteenaho K; Moilanen T; Hämäläinen M; Moilanen E
Osteoarthritis Cartilage; 2002 Apr; 10(4):327-32. PubMed ID: 11950256
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
11. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
12. Biological response modifiers in the management of rheumatoid arthritis.
Louie SG; Park B; Yoon H
Am J Health Syst Pharm; 2003 Feb; 60(4):346-55. PubMed ID: 12625216
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
15. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.
Tanida S; Yoshitomi H; Ishikawa M; Kasahara T; Murata K; Shibuya H; Ito H; Nakamura T
Cytokine; 2011 Aug; 55(2):237-44. PubMed ID: 21592822
[TBL] [Abstract][Full Text] [Related]
16. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
Xiu Z; Shen H; Tian Y; Xia L; Lu J
Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients.
Santos Savio A; Machado Diaz AC; Chico Capote A; Miranda Navarro J; Rodríguez Alvarez Y; Bringas Pérez R; Estévez del Toro M; Guillen Nieto GE
BMC Musculoskelet Disord; 2015 Mar; 16():51. PubMed ID: 25879761
[TBL] [Abstract][Full Text] [Related]
18. Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren AK; Klareskog L; Jakobsson PJ
Arthritis Rheum; 2005 Nov; 52(11):3439-47. PubMed ID: 16255020
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis.
Kan J; Mishima S; Kashiwakura J; Sasaki-Sakamoto T; Seki M; Saito S; Ra C; Tokuhashi Y; Okayama Y
Allergol Int; 2016 Sep; 65 Suppl():S11-6. PubMed ID: 27209051
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
